Flexibilization of Science, Cognitive Biases, and the COVID-19 Pandemic
- PMID: 32861327
- PMCID: PMC7449982
- DOI: 10.1016/j.mayocp.2020.06.037
Flexibilization of Science, Cognitive Biases, and the COVID-19 Pandemic
Figures
Comment on
-
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. Retraction in: Int J Antimicrob Agents. 2025 Jan;65(1):107416. doi: 10.1016/j.ijantimicag.2024.107416. PMID: 32205204 Free PMC article. Retracted. Clinical Trial.
References
-
- Contopoulos-Ioannidis D.G., Ntzani E.E., Ioannidis J.P.A. Translation of highly promising basic science research into clinical applications. Am J Med. 2003;114(6):477–484. - PubMed
-
- Emerson G.B., Warme W.J., Wolf F.M., Heckman J.D., Brand R.A., Leopold S.S. Testing for the presence of positive-outcome bias in peer review: a randomized controlled trial. Arch Intern Med. 2010;170(21):1934–1939. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
